PROGRAM CHAIRS
Lalita Prasad-Reddy, PharmD, FCCP, MS, BCPS, BCACP, CDCES
Assistant Professor of Internal Medicine
Associate Discipline Director of Pharmacology
Rush Medical College
Rush University Medical Center
Chicago, Illinois
Anne Hartley, MD
Assistant Professor
Department of Internal Medicine
Rush University Medical Center
Chicago, Illinois
Lucia M. Novak, MSN, ANP-BC, BC-ADM
President, Diabesity LLC
North Bethesda, Maryland
Co-Executive Director
Capital Health & Metabolic Center
Capital Diabetes & Endocrine Associates
Camp Springs and Silver Spring, Maryland
Nurse Practitioner and Diabetologist, Stability Health
Worcester, Massachusetts
Patient
Julie Mason
PROGRAM OVERVIEW
This Clinical Minutes Satellite Symposium is designed as a case-based learning program to empower clinical pharmacists who actively manage people with T2DM. An interactive discussion among a clinical pharmacist, a nurse practitioner, a primary care provider, and a patient, will highlight the challenges associated with managing diabetes along with obesity and CV risk. The program will highlight the importance of timely treatment intensification, weight management as a core component of diabetes care, and CV risk reduction through guideline-directed therapeutic approaches. Attendees will walk away with practical strategies for integrating newer treatments (such as GLP-1 receptor agonists and SGLT2 inhibitors) into practice, with the goal of optimizing patient outcomes, reducing the risk of long-term complications, and promoting overall health and quality of life for individuals living with T2DM.
TARGET AUDIENCE
This activity is intended for US-based clinical pharmacists who actively manage patients with T2DM in primary care settings and/or have a Collaborative Drug Therapy Management agreement in primary care settings.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply guideline recommendations to ensure timely treatment intensification for patients who require escalation of therapy in the treatment of T2DM
- Implement treatment strategies that prioritize weight management alongside overall glucose control for patients with T2DM
- Summarize evidence-based treatment recommendations for patients with T2DM at high risk of CV disease
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this enduring activity for a maximum of up to 1.0 knowledge-based CPE contact hour.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
ACCME INNOVATION PARTNER DISCLAIMER
Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Lalita Prasad-Reddy, PharmD | Has nothing to disclose. |
| Anne Hartley, MD | Has nothing to disclose. |
| Lucia Novak, MSN | Discloses that she has received consulting fees from Boehringer Ingelheim, Ascensia Diabetes Care, and Nestlé. She has participated on the speakers’ bureaus for Abbott Diabetes Care, Novo Nordisk, and Sanofi. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Surabhi Dangi-Garmiella, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- La Donna Lue Winston, APRN, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Jessica Feygin-Samuels, Program Manager for Med Learning Group, has nothing to disclose.
- Kristen Marks, Program Coordinator for Med Learning Group, has nothing to disclose.
- Russie Allen, MM, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Expert staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: January 09, 2026
EXPIRATION DATE: January 09, 2027
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
